BAX and colorectal carcinoma: The results showed that RSV (0, 6, 12 μg/mL) dose-dependently inhibited CRC cell viability and increased apoptosis and ROS levels, while up-regulating the expression of caspase-3/9 and Bax proteins, down-regulating the expression of Bcl-2.